Dr. Lal PathLabs Ltd
LALPATHLAB • Health Care
ROCE
28.00%
FY24 Actual
D/E Ratio
0.07
Zero Debt
5Y Rev CAGR
13.0%
High Growth
Profit Margin
16.0%
5Y Average
| Metrics (Values in Cr) | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|---|---|
| Total Revenue | 1,632.6 | 2,139.96(+31.1%) | 2,058.6(-3.8%) | 2,295.81(+11.5%) | 2,554.83(+11.3%) | 2,765.9 |
| Operating Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| Operating Profit | — | — | — | — | — | — |
| Raw Profit | 397.26 | 502.25(+26.4%) | 447.15(-11.0%) | 451.42(+1.0%) | 481.46(+6.7%) | — |
| Operating Expenses | 279.11 | 383.56(+37.4%) | 407.22(+6.2%) | 439.65(+8.0%) | 466.58(+6.1%) | 1,928.2 |
| Selling General And Administrative Expenses | 176.29 | 253.82(+44.0%) | 270.25(+6.5%) | 275.58(+2.0%) | 308.24(+11.9%) | — |
| Depreciation And Amortization | 77.2 | 108.11(+40.0%) | 150.19(+38.9%) | 143.6(-4.4%) | 141.92(-1.2%) | 153.6 |
| Profit Before Interest | 410.41 | 505.17(+23.1%) | 381.36(-24.5%) | 534.81(+40.2%) | 647.11(+21.0%) | 684.1 |
| Interest Expense | 16 | 30.18(+88.6%) | 37.53(+24.4%) | 29.36(-21.8%) | 22.31(-24.0%) | 21.7 |
| Profit Before Tax | 394.41 | 474.99(+20.4%) | 343.83(-27.6%) | 505.45(+47.0%) | 624.8(+23.6%) | 662.4 |
| Tax Expense | 102.79 | 130.15(+26.6%) | 104.98(-19.3%) | 147.72(+40.7%) | 137.66(-6.8%) | 134.1 |
| Net Income | 291.62 | 344.84(+18.2%) | 238.85(-30.7%) | 357.73(+49.8%) | 487.14(+36.2%) | 528.3 |
| Earnings Per Share | 17.495 | 20.688(+18.2%) | 14.327(-30.7%) | 21.441(+49.7%) | 29.158(+36.0%) | 31.6 |
| Dividends Per Share | 10 | 6(-40.0%) | 6(0.0%) | 12(+100.0%) | 12(0.0%) | 12.5 |
| Payout Ratio | 0.572 | 0.29(-49.3%) | 0.419(+44.4%) | 0.56(+33.6%) | 0.412(-26.5%) | 0.396 |